Compound Detail
CHEMBL1180
O-DEMETHYLATED ADAPALENE Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1180 |
| Name | O-DEMETHYLATED ADAPALENE |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | LDGIHZJOIQSHPB-UHFFFAOYSA-N |
24
Targets
33
Activities
3
Assay Types
1
PK Parameters
20
Publications
0
Known Names
Molecular Properties
398.5
MW (Da)
6.38
ALogP
2
HBA
2
HBD
57.5
PSA (Ų)
0.54
QED
1
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 25 meas. best 6.89
EC50 5 meas. best 7.31
Ki 3 meas. best 7.11
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Retinoic acid receptor gamma CHEMBL2003 | EC50 | 7.31 | 7.305 | 49.0 | 2 |
| Retinoic acid receptor gamma CHEMBL2003 | Ki | 7.11 | 7.11 | 77.0 | 1 |
| OVCAR-3 CHEMBL614213 | IC50 | 6.89 | 6.89 | 130.0 | 1 |
| Retinoic acid receptor beta CHEMBL2008 | EC50 | 6.65 | 6.65 | 226.0 | 2 |
| DU-145 CHEMBL613508 | IC50 | 6.55 | 6.55 | 280.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 6.52 | 6.3133 | 300.0 | 3 |
| LNCaP CHEMBL612518 | IC50 | 6.5 | 6.5 | 320.0 | 1 |
| ADMET CHEMBL612558 | IC50 | 6.48 | 6.48 | 330.0 | 1 |
| IGROV-1 CHEMBL613984 | IC50 | 6.46 | 6.46 | 350.0 | 3 |
| NB-4 CHEMBL614188 | IC50 | 6.4 | 6.4 | 400.0 | 2 |
| Me665/2/21 CHEMBL614339 | IC50 | 6.38 | 6.38 | 420.0 | 1 |
| PC-3 CHEMBL390 | IC50 | 6.37 | 6.37 | 430.0 | 1 |
| NCI-H460 CHEMBL396 | IC50 | 6.37 | 6.37 | 430.0 | 1 |
| U2OS CHEMBL615023 | IC50 | 6.36 | 6.36 | 440.0 | 1 |
| LoVo CHEMBL614721 | IC50 | 6.31 | 6.31 | 490.0 | 1 |
| A-431 CHEMBL614069 | IC50 | 6.29 | 6.29 | 510.0 | 1 |
| GBM CHEMBL614570 | IC50 | 6.26 | 6.26 | 550.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 6.17 | 6.17 | 680.0 | 1 |
| SAOS-2 CHEMBL614894 | IC50 | 6.17 | 6.17 | 670.0 | 1 |
| QGY-7703 CHEMBL4296490 | IC50 | 5.62 | 5.62 | 2380.0 | 1 |
| Retinoic acid receptor beta CHEMBL2008 | Ki | 5.61 | 5.61 | 2480.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 5.53 | 5.53 | 2930.0 | 1 |
| SMMC-7721 CHEMBL613831 | IC50 | 5.28 | 5.28 | 5250.0 | 1 |
| Retinoic acid receptor alpha CHEMBL2055 | Ki | 5.19 | 5.19 | 6500.0 | 1 |
| L02 CHEMBL4296457 | IC50 | 5.0 | 5.0 | 10080.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 4.92 | 4.92 | 11900.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Fu | 0.0001 | - | Not specified |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4689842 | HEK-293T | 346 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 345 |
| - | 10.6019/CHEMBL4689842 | U2OS | 344 |
| 32184975 | 10.1021/acsmedchemlett.9b00159 | Staphylococcus aureus | 7 |
| 12620066 | 10.1021/jm025593y | IGROV-1 | 4 |
| 16033272 | 10.1021/jm049440h | IGROV-1 | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 32171615 | 10.1016/j.bmcl.2020.127099 | Staphylococcus aureus | 4 |
| 22136251 | 10.1021/jm2011436 | MDA-MB-231 | 4 |
| 12620066 | 10.1021/jm025593y | DU-145 | 4 |
| - | 10.6019/CHEMBL5724696 | TERT-RPE1 | 4 |
| 17489579 | 10.1021/jm0613323 | Unchecked | 2 |
| 29706423 | 10.1016/j.bmcl.2018.04.036 | Unchecked | 2 |
| 21548569 | 10.1021/jm200051z | Retinoic acid receptor alpha | 2 |
| 21548569 | 10.1021/jm200051z | Unchecked | 2 |
| 15214780 | 10.1021/jm030524k | NCI-H460 | 2 |
| 15214780 | 10.1021/jm030524k | MDA-MB-231 | 2 |
| 15214780 | 10.1021/jm030524k | HL-60 | 2 |
| 21548569 | 10.1021/jm200051z | Retinoic acid receptor gamma | 2 |
| 18759424 | 10.1021/jm800456k | ADMET | 2 |
Data from ChEMBL 36 via Core Engine